Research Papers

25 of 388 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator an…
Meijboom RW; Gardarsdottir H; Becker ML; Movig KLL; Kuijvenhoven J; Egberts TCG; Giezen TJ.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
IBD barriers across the continents: a continent-specific analysis - Australasia.
Elford AT; Leong RW; Halmos EP; Morgan M; Kilpatrick K; Lewindon PJ; Gearry RB; Christensen B.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Update on the second-line treatment of <i>Helicobacter pylori</i> infection: a narrative review.
Shih CA; Shie CB; Tai WC; Chuah SK; Lee HC; Hsu PI.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy and safety of vonoprazan-amoxicillin dual therapy for <i>Helicobacter pylori</i> first-line treatment: a singl…
Wang X; Teng G; Dong X; Dai Y; Wang W.
Therap Adv Gastroenterol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Comparison of early aggressive versus nonaggressive fluid resuscitation in acute pancreatitis: a meta-analysis.
Guo J; Hong J; He Y; Li Q; Huang T; Lou D; Zhang J.
Therap Adv Gastroenterol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing.
Argüelles-Arias F; Valdés Delgado T; Maldonado Pérez B; González Antuña J; Castro Laria L.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comparison of high-flow nasal cannula and conventional nasal cannula during sedation for endoscopic submucosal dissecti…
Lee S; Choi JW; Chung IS; Kim DK; Sim WS; Kim TJ.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Because I'm happy - positive affect and its predictive value for future disease activity in patients with inflammatory …
Lang BM; Ledergerber M; Jordi SBU; Krupka N; Biedermann L; Schreiner P; Juillerat P; Wyss J; Vavricka SR; Zeitz J; von Känel R; Rogler G; Beerenwinkel N; Misselwitz B.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a <i>post hoc</i> analysis o…
Rubin DT; Salese L; Cohen M; Kotze PG; Woolcott JC; Su C; Mundayat R; Paulissen J; Torres J; Long MD.
Therap Adv Gastroenterol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX <i>versus</i> 5-aminosalicylates or placebo …
Barberio B; Marsilio I; Buda A; Bertin L; Semprucci G; Zanini A; Crepaldi M; Zingone F; Savarino E.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients f…
Resál T; Bacsur P; Horváth M; Szántó K; Rutka M; Bálint A; Fábián A; Bor R; Szepes Z; Fekete J; Farkas K; Miheller P; Molnár T.
Therap Adv Gastroenterol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Esophageal secondary peristalsis following acid infusion and chemical clearance correlate with mucosal integrity and ac…
Wong MW; Hung JS; Lei WY; Liu TT; Yi CH; Liang SW; Gyawali CP; Wang JH; Chen CL.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Active tuberculosis in inflammatory bowel disease patients: a case-control study.
Freitas Cardoso de Azevedo M; Barros LL; Fernandes Justus F; Oba J; Soares Garcia K; de Almeida Martins C; de Sousa Carlos A; Arruda Leite AZ; Miranda Sipahi A; Queiroz NSF; Omar Mourão Cintra Damião A.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Brief communication: global temporal trends in the efficacy of clarithromycin-based regimens for the treatment of <i>He…
Moss SF; Chey WD; Daniele P; Pelletier C; Jacob R; Tremblay G; Hubscher E; Leifke E; Malfertheiner P.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Managing IBD in the COVID-19 era.
Scalzo N; Ungaro RC.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Safety of fecal microbiota, live-jslm (REBYOTA<sup>™</sup>) in individuals with recurrent <i>Clostridioides difficile</…
Lee C; Louie T; Bancke L; Guthmueller B; Harvey A; Feuerstadt P; Khanna S; Orenstein R; Dubberke ER.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Dietary habits and <i>Helicobacter pylori</i> infection: is there an association?
Soares GAS; Moraes FAS; Ramos AFPL; Santiago SB; Germano JN; Fernandes GA; Curado MP; Barbosa MS.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A review of the role of intermittent fasting in the management of inflammatory bowel disease.
Lavallee CM; Bruno A; Ma C; Raman M.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bo…
Fiorino G; Colombel JF; Katsanos K; Mearin F; Stein J; Andretta M; Antonacci S; Arenare L; Citraro R; Dell'Orco S; Degli Esposti L; Ramirez de Arellano Serna A; Morin N; Koutroubakis IE.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Artificial intelligence in endoscopic ultrasonography: risk stratification of gastric gastrointestinal stromal tumors.
Lu Y; Chen L; Wu J; Er L; Shi H; Cheng W; Chen K; Liu Y; Qiu B; Xu Q; Feng Y; Tang N; Wan F; Sun J; Zhi M.
Therap Adv Gastroenterol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Precision medicine and drug optimization in adult inflammatory bowel disease patients.
Vieujean S; Louis E.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The role of molecular testing in pancreatic cancer.
Zhen DB; Safyan RA; Konick EQ; Nguyen R; Prichard CC; Chiorean EG.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Therapeutic targets in alcohol-associated liver disease: progress and challenges.
Adekunle AD; Adejumo A; Singal AK.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The impact of COVID-19 on endoscopy and cancer screening: a focus on access and equity.
Gardner JG; Feld LD.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The impact of COVID-19 on liver transplantation: challenges and perspectives.
Fatima I; Duong N.
Therap Adv Gastroenterol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared